North America Point of Care Diagnostics Market Analysis and Forecast by Size, Share, Growth, Trends 2031
North America Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
- Status : Published
- Report Code : TIPRE00023729
- Category : Life Sciences
- No. of Pages : 180
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Point of Care Diagnostics Market Landscape
4.1 PEST Analysis
5. North America Point of Care Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. Point of Care Diagnostics Market - North America Market Analysis
6.1 North America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 North America Point of Care Diagnostics Market Forecast and Analysis
7. North America Point of Care Diagnostics Market Revenue Analysis - by Product
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. North America Point of Care Diagnostics Market Revenue Analysis - by Glucose Monitoring
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. North America Point of Care Diagnostics Market Revenue Analysis - by Infectious Disease Testing
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. North America Point of Care Diagnostics Market Revenue Analysis - by Cardio Metabolic Testing
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. North America Point of Care Diagnostics Market Revenue Analysis - by Purchase Mode
11.1 OTC
11.1.1 Overview
11.1.2 OTC: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. North America Point of Care Diagnostics Market Revenue Analysis - by Sample
12.1 Blood
12.1.1 Overview
12.1.2 Blood: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. North America Point of Care Diagnostics Market Revenue Analysis - by End User
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. North America Point of Care Diagnostics Market Revenue Analysis - by Healthcare Facilities
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. North America Point of Care Diagnostics Market - Country Analysis
15.1 North America
15.1.1 North America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 North America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 United States: North America Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 United States: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 United States: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 United States: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 United States: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 United States: North America Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 United States: North America Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 United States: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Canada: North America Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Canada: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Canada: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Canada: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Canada: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Canada: North America Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Canada: North America Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Canada: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 Mexico: North America Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 Mexico: North America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 Mexico: North America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 Mexico: North America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 Mexico: North America Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 Mexico: North America Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 Mexico: North America Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 Mexico: North America Point of Care Diagnostics Market Share - by Healthcare Facilities
17 Industry Landscape
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. Appendix
19.1 About The Insight Partners
List of Tables
Table 1. North America Point of Care Diagnostics Market Segmentation
Table 3. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
List of Figures
Figure 1. North America Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. North America Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. North America Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. North America Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. North America Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. North America Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. North America Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. North America Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. North America Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. North America Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. United States: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Canada: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Mexico: North America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For